Organic compounds -- part of the class 532-570 series inventions 12/06

20060293522 - Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions: P

20060293523 - Novel rhodamine dyes: There are described novel rhodamine color-forming compounds. The rhodamine color-forming compounds exhibit a first color when in a crystalline form and a second color, different from the first color, when in an amorphous form.... Agent: Foley & Lardner LLP

20060293524 - Process for preparation of bisphosphonic acid compounds: The present invention provides a novel process for preparation of bisphosphonic acids or salts thereof, e.g. alendronic acid, by reacting a carboxylic acid, phosphorous acid and a halophosphorous compound in a water miscible neutral solvent.... Agent: Merchant & Gould PC

20060293525 - Optically active alpha-aminooxyketone derivatives and process for production thereof: In the formula, R1 and R2 respectively denote an alkyl, alkenyl or alkynyl group, and R1 and R2 may be linked to form a ring. R3 denotes an aryl, heterocyclic, alkyl, alkenyl or alkynyl group. A denotes a hydrogen atom, alkoxy group, aryloxy group, acyloxy group or silyloxy group which... Agent: Thomas, Kayden, Horstemeyer & Risley, LLP

20060287529 - Solid phase synthesis of antitumoral compounds: Lamellarins are prepared using a solid phase synthesis. In a first aspect, the process includes a step as follows: Formula (I) where R1 to R15 are as defined, and X is halogen, provided that one of R2, R3 or R4 is immobilised to a resin. In a second aspect, the... Agent: Fish & Richardson PC

20060287530 - Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof: The invention relates to a process for preparing new tiotropium salts, these new tiotropium salts as such, pharmaceutical formulations containing them and their use for preparing a medicament.... Agent: Michael P. Morris Boehringer Ingelheim Corporation

20060287531 - Indole, azaindole and related heterocyclic pyrrolidine derivatives: This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the... Agent: Louis J. Wille Bristol-myers Squibb Company

20060287532 - Regiospecific synthesis of nicotine derivatives: Methods of synthesizing nicotine analogs and derivatives are described, The methods are particularly useful for the regioselective production of enantiomerically pure nicotine anlogs having substituents at the C4 position. Intermediates useful for the synthesis of such compounds are also described.... Agent: Myers Bigel Sibley & Sajovec

20060281922 - Detectable threading intercalator: wherein IG1, IG2, and IG3 are the same or different and represent an intercalating group comprising a planar polyaromatic group; wherein DG represents an electrochemical, a chemiluminescent, a catalytic or an electrochemiluminescent detectable group; and wherein n represents 0 or 1. This invention also relates to a process of detecting... Agent: Klarquist Sparkman, LLP

20060281923 - Novel catalysts useful for catalyzing the coupling of arylhalides with arylboronic acids: The present invention relates to a new method of cross-coupling aryl moieties comprising reacting an arylhalide with an arylboronic acid in the presence of a palladium compound and a compound comprising a di-alkylphosphine moiety.... Agent: Woodcock Washburn LLP

20060281924 - Fluorinated dyes or colorants and their uses: This invention relates to novel fluorinated dyes or colorants having high solubility and low viscosity in halogenated, especially fluorinated, solvents. The dyes or colorants of the present invention improve the performance of electrophoretic displays.... Agent: Howrey LLP

20060276651 - Metal complexes: The present invention relates to metal complexes of formula I, compositions comprising the metal complexes, to recording media comprising the metal complexes or compositions and to the use of the compositions in the production of optical recording media: wherein the substituent are, as defined in the description. Use of the...

20060276652 - Preparation of tadalafil intermediates: Provided is a process for preparing tadalafil intermediates in various solvents. Also provided is a method for converting said intermediates to tadalafil....

20060276653 - Process for producing quinoline compound: o

20060276654 - Process of making optically pure l-pipecolic acid and process of making anesthetics and intermediates therefrom: The present invention describes a novel process of preparation of optically pure L-Pipecolic acid and an improved process for the conversion of L-pipecolic acid to L-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide, its hydrochloride salt and hydrochloride monohydrate....

20060276655 - Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia: R4 and R5 are hydrogen or alkyl or form a cycloalkyl ring; A is O or N; and m is zero or one; as inhibitors of GlyT1 and thus as useful for treating or preventing diseases such as schizophrenia; with the provision of pharmaceutical compositions, first and second medical uses...